Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 4, 2015, Pages 1065-1073

  Chiang, Ming Hsien ^a,b   Sung, Wang Chou ^a   Lien, Shu Pei ^a   Chen, Ying Zih ^a   Lo, Annie Fei yun ^a   Huang, Jui Hsin ^a,b   Kuo, Shu Chen ^a,b   Chong, Pele ^a,b,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii; Bioinformatics; Immuno proteomic; Multi drug resistance; Pneumonia; Reverse vaccinology; Vaccine

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN G ANTIBODY; PROTEOME; RECOMBINANT BACTERIAL ANTIGEN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL GENE; BIOINFORMATICS; COMPUTER MODEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PILOT STUDY; PNEUMONIA; PROTEIN EXPRESSION; PROTEOMICS; VACCINATION; WESTERN BLOTTING; ACINETOBACTER INFECTIONS; ANIMAL; BIOLOGY; C57BL MOUSE; HUMAN; IMMUNOLOGY; PROCEDURES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICE; MICE, INBRED C57BL; PNEUMONIA;

EID: 84945192084     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1010910     Document Type: Article

References (58)

1. Behnia M, Logan S, Fallen L, Catalano P. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res Notes 2014; 7:7; PMID:24393391
2. Boerlin P, Eugster S, Gaschen F, Straub R, Schawalder P. Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 2001; 82: 347-59; PMID:11506928; http://dx. doi. org/10. 1016/ S0378-1135(01)00396-0
3. U. S. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. U. S. Centers for Disease Control and Prevention Threat Report.
4. Kuo L-CC, Lai C-CC, Liao C-HH, Hsu C-KK, Chang Y-LL, Chang CY, Hsueh PR. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007; 13:196-8; PMID:17328733; http://dx. doi. org/10. 1111/j. 1469-0691. 2006. 01601. x
5. Suetens C, Hopkins S, Kolman J, Högberg LD. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Euro Centre Dis Prevent Control 2013: 1-5.
6. Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol 2012; 15:596-602; PMID:22981392; http://dx. doi. org/10. 1016/j. mib. 2012. 08. 002
7. Pachón J, McConnell MJ. Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii. Vaccine 2014; 32:2534-6; PMID:24188749; http://dx. doi. org/10. 1016/j. vaccine. 2013. 10. 064
8. McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 2011; 79:518-26; PMID: 20974823; http://dx. doi. org/10. 1128/IAI. 00741-10
9. McConnell MJ, Pachón J. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 2010; 29:1-5; PMID:21044668; http://dx. doi. org/10. 1016/j. vaccine. 2010. 10. 052
10. Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, Kim SA, Lee SK, Lee JC. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005; 7:1127-38; PMID:16008580; http:// dx. doi. org/10. 1111/j. 1462-5822. 2005. 00538. x
11. Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho- Peiro A, Pier GB, Maira-Litrán T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun 2012; 80:3381-8; PMID:22825448; http://dx. doi. org/10. 1128/IAI. 06096-11
12. Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 2011; 51:402-6; PMID:21946278; http://dx. doi. org/10. 1016/j. micpath. 2011. 09. 004
13. Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 2012; 80:651-6; PMID:22104104; http://dx. doi. org/ 10. 1128/IAI. 05653-11
14. Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke- Marshall NR, Campagnari AA. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 2013; 81:915-22; PMID:23297385; http://dx. doi. org/10. 1128/IAI. 01184-12
15. Bambini S, Rappuoli R. The use of genomics in microbial vaccine development. Drug Dis Today 2009; 14:252-60; PMID:19150507; http://dx. doi. org/ 10. 1016/j. drudis. 2008. 12. 007
16. Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010; 33:530-41; PMID:21029963; http://dx. doi. org/ 10. 1016/j. immuni. 2010. 09. 017
17. Moriel DG, Beatson SA, Wurpel DJ, Lipman J, Nimmo GR, Paterson DL, Schembri MA. Identification of novel vaccine candidates against multidrugresistant Acinetobacter baumannii. PloS One 2013; 8: e77631; PMID:24116234; http://dx. doi. org/10. 1371/ journal. pone. 0077631
18. Kwon S-OO, Gho YS, Lee JC, Kim SI. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett 2009; 297:150-6; PMID:19548894; http://dx. doi. org/ 10. 1111/j. 1574-6968. 2009. 01669. x
19. Jun SH, Lee JH, Kim BR, Kim SI, Park TI, Lee JC, Lee YC. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PloS One 2013; 8:e71751; PMID:23977136; http://dx. doi. org/10. 1371/journal. pone. 0071751
20. Karlsen C, Espelid S, Willassen N-PP, Paulsen SM. Identification and cloning of immunogenic Aliivibrio salmonicida Pal-like protein present in profiled outer membrane and secreted subproteome. Dis Aquat Organ 2011; 93:215-23; PMID:21516974; http://dx. doi. org/10. 3354/dao02302
21. King LB, Pangburn MK, McDaniel LS. Serine protease PKF of Acinetobacter baumannii results in serum resistance and suppression of biofilm formation. J Infect Dis 2013; 207:1128-34; PMID:23303803; http://dx. doi. org/10. 1093/infdis/jis939
22. Mendez JA, Soares NC, Mateos J, Gayoso C, Rumbo C, Aranda J, Tomas M, Bou G. Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. J Proteome Res 2012; 11:5678-94; PMID:22966805
23. Moganty R, Vashistt J, Tiwari V, Kapil A. Differential expression of Outer membrane proteins in early stages of meropenem-resistance in Acinetobacter baumannii. J Integrat OMICS 2011; 1(2):281-287; http://dx. doi. org/10. 5584/jiomics. v1i2. 67
24. Ponomarenko EA, Lisitsa AV, Petrak J, Moshkovskii SA, Archakov AI. Identification of differentially expressed proteins using automated meta-analysis of proteomic articles. Biomed Khim 2009; 3:10-16; PMID:19351029; http://dx. doi. org/10. 1134/ S1990750809010028
25. Siroy A, Cosette P, Seyer D, Lemaître-Guillier C, Vallenet D, Van Dorsselaer A, Boyer-Mariotte S, Jouenne T, Dé E. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 2006; 5:3385-98; PMID:17137340; http://dx. doi. org/ 10. 1021/pr060372s
26. Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S, Bataille E, Dossat C, Gas S, Kreimeyer A, Lenoble P, et al. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PloS One 2008; 3:e1805; PMID:18350144; http://dx. doi. org/10. 1371/journal. pone. 0001805
27. Vashist J, Tiwari V, Kapil A, Rajeswari MR. Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J Proteome Res 2010; 9:1121-8; PMID:20041708; http://dx. doi. org/10. 1021/ pr9011188
28. Yun S-HH, Choi C-WW, Kwon S-OO, Park GW, Cho K, Kwon KH, Kim JY, Yoo JS, Lee JC, Choi JS, et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res 2011; 10:459-69; PMID:21053951; http://dx. doi. org/ 10. 1021/pr101012s
29. Li N, Yang Z, Bai J, Fu X, Liu L, Shi C, Wu S. A shared antigen among Vibrio species: outer membrane protein-OmpK as a versatile Vibriosis vaccine candidate in Orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immun 2010; 28:952-6; PMID:20170736; http://dx. doi. org/10. 1016/j. fsi. 2010. 02. 010
30. Kuolee R, Harris G, Yan H, Xu HH, Conlan WJ, Patel GB, Chen W. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. Vaccine 2015; 33(1):260-7; PMID:24699469; http://dx. doi. org/10. 1016/j. vaccine. 2014. 02. 083. [Epub ahead of print]
31. Harris G, KuoLee R, Lam CK, Kanzaki G, Patel GB, Xu HH, Chen W. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 2013; 57:3601-13; PMID:23689726; http://dx. doi. org/10. 1128/AAC. 00944-13
32. Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PloS One 2012; 7:e29446; PMID:22253723; http://dx. doi. org/10. 1371/journal. pone. 0029446
33. McConnell MJ, Rumbo C, Bou G, Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011; 29:5705-10; PMID:21679737; http://dx. doi. org/10. 1016/j. vaccine. 2011. 06. 001
34. Uchiyama I, Mihara M, Nishide H, Chiba H. MBGD update 2013: the microbial genome database for exploring the diversity of microbial world. Nucl Acids Res 2013; PMID:23118485; http://dx. doi. org/ 10. 1093/nar/gks1006
35. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6. 0. Mol Biol Evolut 2013; 30:2725-9; PMID:24132122; http://dx. doi. org/10. 1093/molbev/ mst197
36. Tatusov RL, Galperin MY, Natale DA, Koonin EV. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucl Acids Res 2000; 28:33-6; PMID:10592175; http://dx. doi. org/10. 1093/ nar/28. 1. 33
37. Farrugia D, Elbourne L, Hassan K, Eijkelkamp B, Tetu S, Brown MH, Shah BS, Peleg AY, Mabbutt BC, Paulsen IT. The complete genome and phenome of a community- acquired Acinetobacter baumannii. PloS One 2013; 8:e58628; PMID:23527001; http://dx. doi. org/ 10. 1371/journal. pone. 0058628
38. Ningqiu L, Junjie B, Shuqin W, Xiaozhe F, Haihua L, Xing Y, Cunbin S. An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immunol 2008; 25(6):829-833; PMID:18854216; http://dx. doi. org/10. 1016/j. fsi. 2008. 09. 007
39. Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, Aftalion M, Elhanany E, Zvi A, Shafferman A, et al. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PloS One 2009; 4:e7023; PMID:19759820; http://dx. doi. org/10. 1371/journal. pone. 0007023
40. Cameron CE, Lukehart SA, Castro C, Molini B, Godornes C, Van Voorhis WC. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92. J Infect Dis 2000; 181(4):1401-1413; PMID:10762571; http://dx. doi. org/10. 1086/315399
41. Mitchison M, Wei L, Kwang J, Wilkie I, Adler B. Overexpression and immunogenicity of the Oma87 outer membrane protein of Pasteurella multocida. Vet Microbiol 2000; 72:91-6; PMID:10699506; http://dx. doi. org/10. 1016/S0378-1135(99)00190-X
42. Karlsen C, Espelid S, Willassen N-PP, Paulsen SM. Identification and cloning of immunogenic Aliivibrio salmonicida Pal-like protein present in profiled outer membrane and secreted subproteome. Dis Aquat Organ 2011; 93(3):215-223; PMID:21516974; http:// dx. doi. org/10. 3354/dao02302
43. Doyle CR, Pan J-AA, Mena P, Zong W-XX, Thanassi DG. TolC-dependent modulation of host cell death by the Francisella tularensis live vaccine strain. Infect Immun 2014; 82:2068-78; PMID:24614652; http:// dx. doi. org/10. 1128/IAI. 00044-14
44. Martínez-Martínez S, Frandoloso R, Rodríguez Ferri EF, Gil C, Hernández-Haro C, Yubero S, Gutiérrez Martín CB. Immunoproteomic analysis of the protective response obtained with subunit and commercial vaccines against Glässer's disease in pigs. Vet Immunol Immunopathol 2013; 151(3-4):235-247; PMID:23266097; http://dx. doi. org/10. 1016/j. vetimm. 2012. 11. 014
45. Kim YH, Kim KA, Kim Y-RR, Choi MK, Kim HK, Choi KJ, Chun JH, Cha K, Hong KJ, Lee NG, et al. Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine. Proteomics 2014; 14 (1):93-104; PMID:24273028; http://dx. doi. org/ 10. 1002/pmic. 201200495
46. Santos-Gomes GM, Rodrigues A, Teixeira F, Carreira J, Alexandre-Pires G, Carvalho S, Santos- Mateus D, Martins C, Vale-Gato I, Marques C, et al. Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells. Vaccine 2014; 32:1247-53; PMID:24486368; http://dx. doi. org/ 10. 1016/j. vaccine. 2014. 01. 024
47. Yu Q, Huang X, Gong P, Zhang Q, Li J, Zhang G, Yang J, Li H, Wang N, Zhang X. Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii. Vaccine 2013; 31:6065-71; PMID:24176493; http://dx. doi. org/ 10. 1016/j. vaccine. 2013. 10. 015
48. Ghaffarifar F, Jorjani O, Sharifi Z, Dalimi A, Hassan ZM, Tabatabaie F, Khoshzaban F, Hezarjaribi HZ. Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major. APMIS 2013; 121:290-8; PMID:23030526; http://dx. doi. org/ 10. 1111/j. 1600-0463. 2012. 02968. x
49. Sangpairoj K, Changklungmoa N, Vanichviriyakit R, Sobhon P, Chaithirayanon K. Analysis of the expression and antioxidant activity of 2-Cys peroxiredoxin protein in Fasciola gigantica. Exp Parasitol 2014; 140:24-32; PMID:24594261; http://dx. doi. org/ 10. 1016/j. exppara. 2014. 02. 017
50. Mes TH, van Putten JP. Positively selected codons in immune-exposed loops of the vaccine candidate OMPP1 of Haemophilus influenzae. J Mol Evol 2007; 64:411-22; PMID:17479342; http://dx. doi. org/ 10. 1007/s00239-006-0021-2
51. Yang T-CC, Ma X-CC, Liu F, Lin L-RR, Liu L-LL, Liu GL, Tong ML, Fu ZG, Zhou L. Screening of the Salmonella paratyphi A CMCC 50973 strain outer membrane proteins for the identification of potential vaccine targets. Mol Med Rep 2012; 5:78-83; PMID:21922141
52. Sakolvaree Y, Maneewatch S, Jiemsup S, Klaysing B, Tongtawe P, Srimanote P, Saengjaruk P, Banyen S, Tapchaisri P, Chonsa-nguan M, et al. Proteome and immunome of pathogenic Leptospira spp. revealed by 2DE and 2DE-immunoblotting with immune serum. Asian Pac J Allergy Immunol 2007; 25(1):53-73; PMID:17891922
53. Gates AE, Frasca S, Nyaoke A, Gorton TS, Silbart LK, Geary SJ. Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis. Vaccine 2008; 26:2010-9; PMID: 18342996; http://dx. doi. org/10. 1016/j. vaccine. 2008. 02. 010
54. Whiting GC, Rijpkema S, Adams T, Corbel MJ. Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis. Vaccine 2004; 22:4245- 4251; PMID:15474715; http://dx. doi. org/10. 1016/j. vaccine. 2004. 04. 036
55. Havlasová J, Hernychová L, Brychta M, Hubálek M, Lenco J, Larsson P, Lundqvist M, Forsman M, Krocová Z, Stulík J, et al. A Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 2005; 5:2090-103; PMID:15892173; http://dx. doi. org/10. 1002/pmic. 200401123
56. Ali A, Soares SC, Santos AR, Guimarães LC, Barbosa E, Almeida SS, Abreu VA, Carneiro AR, Ramos RT, Bakhtiar SM, et al. Campylobacter fetus subspecies: comparative genomics and prediction of potential virulence targets. Gene 2012; 508(2):145-156; PMID:22890137; http://dx. doi. org/10. 1016/j. gene. 2012. 07. 070
57. Perez F, Bonomo RA. Vaccine for Acinetobacter baumannii: Thinking "out of the box". Vaccine 2014; 32 (22):2537-9; PMID:24662709; http://dx. doi. org/ 10. 1016/j. vaccine. 2014. 03. 031
58. Umland TC, Schultz LW, MacDonald U, Beanan JM, Olson R, Russo TA. In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media. mBio 2012; 3 (4):e00113-12; PMID: 22911967; http://dx. doi. org/10. 1128/mBio. 00113-12